Blood filtration for septic shock study
Part of Infections clinical trials.
This trial tests whether a blood-filtering device can help people with septic shock by removing harmful substances from the blood. It is for adults who have been diagnosed with septic shock within the last 24 hours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with septic shock within the last 24 hours.
- You have a large-bore IV line in place.
- You are willing to have a legal representative sign a consent form if needed.
- You are not pregnant.
- You have not had certain recent treatments like high-dose steroids, chemotherapy, or biologic drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
This trial looks at whether a blood-filter treatment (called “AN69ST Verse PS” using a hemofilter) can help children with early, serious sepsis and poor circulation or organ problems. It may help stabilize the body faster, but eligibility is limited to certain sepsis situations and recent timing.
This study tests whether a blood-filter treatment called hemoperfusion can help critically ill people with sepsis that is not responding to standard shock treatment and is affecting multiple organs. It aims to improve recovery when infections are controlled and inflammation markers are very high.
This trial tests whether a special type of dialysis filter (oXiris) helps reduce blood clotting problems in patients with septic shock and kidney failure. It may offer a better option for those needing kidney support in the ICU.
This trial studies a blood-cleaning treatment in children with early, serious sepsis to see if it helps organs recover. It’s meant for children who are very sick soon after sepsis starts.
This trial tests a device that filters extra DNA from the blood of people with septic shock. It may help reduce inflammation and improve recovery.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.